 Connection
Jill Johnson to Humans
This is a "connection" page, showing publications Jill Johnson has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.124 |
|
|
|
-
Golden W, Peng C, Shoptaw EJ, Painter J, Dare R, Thomas J, Maples H, Teeter B, Johnson J. Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program. Ann Fam Med. 2025 Sep 22; 23(5):407-411.
Score: 0.041
-
King J, McAdam-Marx C, McCaleb R, Davis D, Bemberg GB, Johnson JT. Cost and Utilization Outcomes After Exclusion of Dipeptidyl Peptidase-4 Inhibitors and Other Diabetes Drug Category Changes in a Self-Funded, State Employee Managed Care Plan. J Manag Care Spec Pharm. 2019 Jun; 25(6):646-651.
Score: 0.026
-
Dayer LE, Hutchins LF, Johnson JT. Treatment of metastatic melanoma with pazopanib: A report of five patient cases. J Oncol Pharm Pract. 2015 Jun; 21(3):224-31.
Score: 0.018
-
Neill KK, Johnson JT. An advanced pharmacy practice experience in application of evidence-based policy. Am J Pharm Educ. 2012 Sep 10; 76(7):133.
Score: 0.016
-
Johnson JT, Neill KK, Davis DA. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan. J Manag Care Pharm. 2011 Apr; 17(3):200-12.
Score: 0.015
-
Shewale AR, Johnson JT, Li C, Nelsen D, Martin BC. Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2015 Dec; 24(12):2845-53.
Score: 0.005
-
West DS, Johnson JT, Hong SH. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan. J Manag Care Pharm. 2006 Jan-Feb; 12(1):25-32.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|